ClinicalTrials.gg
Active, not recruitingNCT06163248ChronoUpdated Nov 3, 2026

Chrono Nutrition and Insulin Resistance in Diabetes

An interventional study of Chrono nutrition and Standard in Diabetes Mellitus, Type 2, sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran. Active, not recruiting at 1 site in Mexico. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Now Active, not recruitingPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 10 studies in Diabetes Mellitus, Type 2 by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — 3 open to participants now, 5 under way, none of them phase 3. Diabetes Mellitus, Type 2 · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.

Started
2024
with 1 other
No phase
6 of 10
1 open now
Registered
7th of 10
by date

Among the 10 studies in Diabetes Mellitus, Type 2 by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, this one is one of 2 that started in 2024, is one of 6 with no phase, and was the 7th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

3 of the 10 studies in Diabetes Mellitus, Type 2 by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Diabetes Mellitus, Type 2 by Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, or all of them as a file.
02

Study summary

The goal of this randomized clinical trial is to determine the effect of a chrono nutrition intervention compared with a usual dietary intervention on insulin resistance in individuals with type 2 diabetes with overweight or obesity over a 6-month period.

The main question it aims to answer is: What is the effect of a chrono nutrition intervention compared to a standard intervention on insulin resistance in individuals with T2D (type 2 diabetes) with overweight or obesity over a 6-month period?

Participants:

  • Will be asked to fast for 12 hours each day. During the fasting period, they may consume non-caloric beverages such as plain water, coffee, or unsweetened tea.
  • They will be asked to follow a dietary plan in which the total daily calorie intake will be calculated using indirect calorimetry, subtracting 500 calories from the total calorie amount.
  • The dietary plan will have the following macronutrient distribution: 40% carbohydrates (\<10% simple carbohydrates), 20% protein, and 40% fats (6-11% polyunsaturated, 15-20% monounsaturated, and \<10% saturated).
  • The plan will consist of 3 meals: breakfast will account for 40% of the total calories. Dinner will include only 10% of the total grams of carbohydrates.
  • The order of food consumption should be: 1) vegetables, 2) proteins, 3) complex carbohydrates, and 4) simple carbohydrates (fruits).

Researchers will compare the chrono nutrition strategy with a standard dietary intervention to see the effect in insulin resistance.

Read the detailed description

Type 2 diabetes (T2D) is considered one of the main public health problems. During the last decade the incidence of T2D has increased exponentially leading to an increased incidence in cardiovascular disease, premature death, blindness and non-traumatic limb amputation. Novel therapeutic interventions have become imperative.

Dietary interventions are the cornerstone in managing and preventing T2D, however there is heterogeneity in the interventions and approaches currently available. The main objective of a dietary intervention is modest weight reduction achieved through calorie deficit and reduction in the consumption of carbohydrates and fats. Dietary interventions with a chrono nutrition focus establish an eating regime with calorie and macronutrient distribution taking into account sleeping and fasting hours, which are associated with metabolic alterations. This approach looks beyond calorie deficit and weight loss as primary outcomes.

Nutrition, physical activity, and education are fundamental pillars for achieving metabolic control in T2D. It is well-described that a nutritional treatment alone can improve glycemic control and the quality of life of patients. It is interesting to note that the timing of meals throughout the 24-hour period seems to play an important role, similar to the number of meals per day or the total calorie intake. Furthermore, the daily pattern of fasting-feeding is influenced by the sleep-wake cycle pattern, which is one of the most evident adaptations to circadian rhythms and plays a significant role in maintaining optimal health.

Interventions targeting aspects such as food type, meal timing, quality, and quantity can be a simple and promising strategy that can positively or negatively impact metabolic health, regardless of body weight modification. This evidence supports chrono nutrition as a novel strategy in the field of nutrition, primarily focusing on studying the interaction between nutrition, feeding, and the circadian rhythm. The implementation of new nutritional strategies based on circadian rhythms contributes to improving adherence to dietary treatment and preventing potential complications.

03

Conditions studied

  • Diabetes Mellitus, Type 2

Keywords

  • Diabetes mellitus
  • Chrono nutrition
  • Insulin resistance
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with type 2 diabetes (T2D)
  • \< 8.5%
  • ≥ 25 kg/m2 and \< 35 kg/m2
  • Stable pharmacological treatment for the last 3 months
  • Willingness to participate in the protocol.

Exclusion criteria

Exclusion Criteria:

  • Insulin treatment
  • Hospitalization in the previous three months
  • Disease with adverse prognosis (SIDA, cancer)
  • Rheumatologic diseases under treatment (SLE, RA)
  • Acute infection or febrile syndrome
  • Hepatic cirrhosis
  • \<60 ml/min
  • Other diabetes types (LADA, T1, MODY)
  • Fasting triglycerides >500 mg/dl
  • Pregnancy
  • Lactation
  • treatment
  • High performance athletes
  • Estrogen treatment
  • Weight reduction >5% in the last three months
Terms in these criteria, in plain language(5)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Chrono nutrition

    1. During the 6-month period, participants will be asked to fast for 12 hours each day. During the fasting period, they may consume non-caloric beverages such as plain water, coffee, or unsweetened tea. 2. The total daily calorie intake will be calculated using indirect calorimetry, considering the participant's current weight, age, sex, and physical activity level. 500 calories will be subtracted from the total calorie amount. 3. The dietary plan will have the following macronutrient distribution: 40% carbohydrates (\<10% simple carbohydrates), 20% protein, and 40% fats (6-11% polyunsaturated, 15-20% monounsaturated, and \<10% saturated). 4. The plan will consist of 3 meals and breakfast will account for 40% of the total calories. 5. During dinner, only 10% of the total grams of carbohydrates will be included. 6. The order of food consumption should be as follows: 1) vegetables, 2) proteins, 3) complex carbohydrates, and 4) simple carbohydrates (fruits).

    Other: Chrono nutrition

  • Active comparator
    Standard

    1. The total daily calorie intake will be calculated using indirect calorimetry, considering the participant's current weight, age, sex, and physical activity level. 500 calories will be subtracted from the total calorie amount. 2. The dietary plan will have the following macronutrient distribution: 40% carbohydrates (\<10% simple carbohydrates), 20% protein, and 40% fats (6-11% polyunsaturated, 15-20% monounsaturated, and \<10% saturated). 3. The plan will consist of 3 meals with an isocaloric distribution, with each meal containing 33% of the total calories.

    Other: Standard

Interventions

  • OtherChrono nutrition

    An integral nutritional strategy involving timing, order and distribution of macronutrients

  • OtherStandard

    Conventional nutritional strategy involving isocaloric distribution with no specific timing

06

What researchers measure

Primary outcomes

  1. Change in insulin resistance (M value)

    Change in insulin resistance (M value) assessed with an euglycemic-hyperinsulinemic clamp.

    Time frame: Six months

Secondary outcomes

  1. Change in visceral adipose (liters)

    Change in visceral adipose tissue amount

    Time frame: Six months

  2. Change in glycated hemoglobin (%)

    Change in glycated hemoglobin

    Time frame: Six months

  3. Change in lipid profile (mg/dl)

    Change in lipid profile

    Time frame: Six months

Other outcomes

  1. Change in hepatic steatosis and fibrosis (decibels and kilopascals)

    Change in hepatic steatosis and fibrosis assessed with elastography

    Time frame: Six months

  2. Hunger and satiety (score)

    Change in hunger and satiety assessed with visual analog scale for hunger and satiety

    Time frame: Six months

07

Study locations

1 site
08

References and documents

Publications

  • Henry CJ, Kaur B, Quek RYC. Chrononutrition in the management of diabetes. Nutr Diabetes. 2020 Feb 19;10(1):6. doi: 10.1038/s41387-020-0109-6. PubMed 32075959 ↗
  • Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005 Jan;81(1):16-24. doi: 10.1093/ajcn/81.1.16. PubMed 15640455 ↗
  • Stote KS, Baer DJ, Spears K, Paul DR, Harris GK, Rumpler WV, Strycula P, Najjar SS, Ferrucci L, Ingram DK, Longo DL, Mattson MP. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am J Clin Nutr. 2007 Apr;85(4):981-8. doi: 10.1093/ajcn/85.4.981. PubMed 17413096 ↗
  • Lopez-Minguez J, Saxena R, Bandin C, Scheer FA, Garaulet M. Late dinner impairs glucose tolerance in MTNR1B risk allele carriers: A randomized, cross-over study. Clin Nutr. 2018 Aug;37(4):1133-1140. doi: 10.1016/j.clnu.2017.04.003. Epub 2017 Apr 10. PubMed 28455106 ↗
  • Jakubowicz D, Wainstein J, Landau Z, Ahren B, Barnea M, Bar-Dayan Y, Froy O. High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA1C in Type 2 diabetes. J Nutr Biochem. 2017 Nov;49:1-7. doi: 10.1016/j.jnutbio.2017.07.005. Epub 2017 Jul 21. PubMed 28863364 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Apr 2027, 39 months after the start.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 39 months is above that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Mar 2025 → Apr 2027 and completion Jan 2026 → Aug 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2023
First posted
Dec 8, 2023
StartActual
Jan 1, 2024
Primary completionEst.
Apr 1, 2027was Mar 2025
CompletionEst.
Aug 1, 2027was Jan 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Active, not recruiting
changed Nov 3, 2026
Sites
1 site added, 1 site removed
Show site
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Mexico City, Mexico
Show 1 removed
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Mexico City, Mexico
Nov 3, 2026
Primary completion
Mar 1, 2025→Apr 1, 2027
Nov 3, 2026
Study completion
Jan 1, 2026→Aug 1, 2027
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Enrolling by invitation→Active, not recruiting
    1 site added, 1 site removed
    Show site
    • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Mexico City, Mexico
    Show 1 removed
    • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Mexico City, Mexico
    Primary completion Mar 1, 2025→Apr 1, 2027
    Study completion Jan 1, 2026→Aug 1, 2027
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06163248
Responsible party
Sponsor
First posted
Dec 8, 2023
Start date
Jan 1, 2024
Primary completion
Apr 1, 2027 (estimated)
Completion
Aug 1, 2027 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion